Certuity’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Certuity’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-900	Closed	-$101K	–	225
2020 Q2	$101K	Buy	+900	New	+$88.6K	0.05%	175

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Certuity's XBI Position: Q2 2026 in Review

Certuity increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.1% in Q2 2026, buying an estimated $19.7K and bringing the position to 7,116 shares worth $1.13M. The position accounts for 0.06% of the portfolio, ranked #162.

Certuity first reported a position in XBI in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.26M in Q2 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Certuity held 7,116 shares of State Street SPDR S&P Biotech ETF worth $1.13M as of Q2 2026.
Certuity bought 146 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $19.7K.
State Street SPDR S&P Biotech ETF made up 0.06% of Certuity's portfolio in Q2 2026, its #162 holding.
Certuity first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 27 quarters since.
Certuity's State Street SPDR S&P Biotech ETF position peaked at $2.26M in Q2 2021.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.